Cortactin and Fascin-1 Regulate Extracellular Vesicle Release by Controlling Endosomal Trafficking or Invadopodia Formation and Function

Overview

Journal Sci Rep

Specialty Science

Date 2018 Oct 25

PMID 30353022

Citations 29

Authors

Els Beghein

Delphine Devriese

Evy Van Hoey

Jan Gettemans

Affiliations

Soon will be listed here.

Abstract

Cancer cell-derived extracellular vesicles (EVs) are increasingly being recognized as genuine invasive structures as they contribute to many aspects of invasion and metastasis. Unfortunately, the mechanisms underlying EV biogenesis or release are still poorly understood. Recent reports however indicate a role of the actin cytoskeleton in this process. In this study, we have exploited thoroughly characterized camelid nanobodies against actin binding proteins cortactin and fascin-1, a branched actin regulator and actin bundler, respectively, in order to assess their roles in EV biogenesis or release. Using this strategy, we demonstrate a role of the cortactin NTA and SH3 domains in EV release. Fascin-1 also regulates EV release, independently of its actin-bundling activity. We show a contribution of these protein domains in endosomal trafficking, a crucial step in EV biogenesis, and we confirm that EVs are preferentially released at invadopodia, the latter being actin-rich invasive cell protrusions in which cortactin and fascin-1 perform essential roles. Accordingly, EVs are enriched with invadopodial proteins such as the matrix metalloproteinase MT1-MMP and exert gelatinolytic activity. Based on our findings, we report that both cortactin and fascin-1 play key roles in EV release by regulating endosomal trafficking or invadopodia formation and function.

Citing Articles

Endometriosis and Cytoskeletal Remodeling: The Functional Role of Actin-Binding Proteins.

Arendt W, Kleszczynski K, Gagat M, Izdebska M Cells. 2025; 14(5).

PMID: 40072086 PMC: 11898689. DOI: 10.3390/cells14050360.

Maternal microchimeric cell trafficking and its biological consequences depend on the onset of inflammation at the feto-maternal interface.

Slaats E, Bramreiter B, Chua K, Quilang R, Sallinger K, Eikmans M Semin Immunopathol. 2025; 47(1):8.

PMID: 39820729 PMC: 11742462. DOI: 10.1007/s00281-025-01037-w.

Role of actin-binding proteins in prostate cancer.

Fu F, Yu Y, Zou B, Long Y, Wu L, Yin J Front Cell Dev Biol. 2024; 12:1430386.

PMID: 39055653 PMC: 11269120. DOI: 10.3389/fcell.2024.1430386.

Extracellular vesicles as tools and targets in therapy for diseases.

Kumar M, Baba S, Sadida H, Al Marzooqi S, Jerobin J, Altemani F Signal Transduct Target Ther. 2024; 9(1):27.

PMID: 38311623 PMC: 10838959. DOI: 10.1038/s41392-024-01735-1.

Fascin-1 in Cancer Cell Metastasis: Old Target-New Insights.

Sarantelli E, Mourkakis A, Zacharia L, Stylianou A, Gkretsi V Int J Mol Sci. 2023; 24(14).

PMID: 37511011 PMC: 10379093. DOI: 10.3390/ijms241411253.

References

Ostrowski M, Carmo N, Krumeich S, Fanget I, Raposo G, Savina A . Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2009; 12(1):19-30. DOI: 10.1038/ncb2000. View

Schoumacher M, Goldman R, Louvard D, Vignjevic D . Actin, microtubules, and vimentin intermediate filaments cooperate for elongation of invadopodia. J Cell Biol. 2010; 189(3):541-56. PMC: 2867303. DOI: 10.1083/jcb.200909113. View

Sauvonnet N, Dujeancourt A, Dautry-Varsat A . Cortactin and dynamin are required for the clathrin-independent endocytosis of gammac cytokine receptor. J Cell Biol. 2004; 168(1):155-63. PMC: 2171671. DOI: 10.1083/jcb.200406174. View

Beghein E, Van Audenhove I, Zwaenepoel O, Verhelle A, De Ganck A, Gettemans J . A new survivin tracer tracks, delocalizes and captures endogenous survivin at different subcellular locations and in distinct organelles. Sci Rep. 2016; 6:31177. PMC: 4981888. DOI: 10.1038/srep31177. View

Sung B, Zhu X, Kaverina I, Weaver A . Cortactin controls cell motility and lamellipodial dynamics by regulating ECM secretion. Curr Biol. 2011; 21(17):1460-9. PMC: 3175319. DOI: 10.1016/j.cub.2011.06.065. View

Cao H, Orth J, Chen J, Weller S, Heuser J, McNiven M . Cortactin is a component of clathrin-coated pits and participates in receptor-mediated endocytosis. Mol Cell Biol. 2003; 23(6):2162-70. PMC: 149460. DOI: 10.1128/MCB.23.6.2162-2170.2003. View

Zhang Y, Nolan M, Yamada H, Watanabe M, Nasu Y, Takei K . Dynamin2 GTPase contributes to invadopodia formation in invasive bladder cancer cells. Biochem Biophys Res Commun. 2016; 480(3):409-414. DOI: 10.1016/j.bbrc.2016.10.063. View

Yamaguchi H, Lorenz M, Kempiak S, Sarmiento C, Coniglio S, Symons M . Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin. J Cell Biol. 2005; 168(3):441-52. PMC: 2171731. DOI: 10.1083/jcb.200407076. View

Kirkbride K, Sung B, Sinha S, Weaver A . Cortactin: a multifunctional regulator of cellular invasiveness. Cell Adh Migr. 2011; 5(2):187-98. PMC: 3084985. DOI: 10.4161/cam.5.2.14773. View

10.

Van den Abbeele A, De Clercq S, De Ganck A, De Corte V, Van Loo B, Soror S . A llama-derived gelsolin single-domain antibody blocks gelsolin-G-actin interaction. Cell Mol Life Sci. 2010; 67(9):1519-35. PMC: 11115616. DOI: 10.1007/s00018-010-0266-1. View

11.

Schnaeker E, Ossig R, Ludwig T, Dreier R, Oberleithner H, Wilhelmi M . Microtubule-dependent matrix metalloproteinase-2/matrix metalloproteinase-9 exocytosis: prerequisite in human melanoma cell invasion. Cancer Res. 2004; 64(24):8924-31. DOI: 10.1158/0008-5472.CAN-04-0324. View

12.

Villarreal L, Mendez O, Salvans C, Gregori J, Baselga J, Villanueva J . Unconventional secretion is a major contributor of cancer cell line secretomes. Mol Cell Proteomics. 2012; 12(5):1046-60. PMC: 3650320. DOI: 10.1074/mcp.M112.021618. View

13.

Renicke C, Schuster D, Usherenko S, Essen L, Taxis C . A LOV2 domain-based optogenetic tool to control protein degradation and cellular function. Chem Biol. 2013; 20(4):619-26. DOI: 10.1016/j.chembiol.2013.03.005. View

14.

Cao H, Chen J, Krueger E, McNiven M . SRC-mediated phosphorylation of dynamin and cortactin regulates the "constitutive" endocytosis of transferrin. Mol Cell Biol. 2009; 30(3):781-92. PMC: 2812239. DOI: 10.1128/MCB.00330-09. View

15.

Ji H, Greening D, Barnes T, Lim J, Tauro B, Rai A . Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components. Proteomics. 2013; 13(10-11):1672-86. DOI: 10.1002/pmic.201200562. View

16.

Beaty B, Condeelis J . Digging a little deeper: the stages of invadopodium formation and maturation. Eur J Cell Biol. 2014; 93(10-12):438-44. PMC: 4262566. DOI: 10.1016/j.ejcb.2014.07.003. View

17.

Jackson A, Linsley P . Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Nat Rev Drug Discov. 2010; 9(1):57-67. DOI: 10.1038/nrd3010. View

18.

Clark E, Brown B, Whigham A, Kochaishvili A, Yarbrough W, Weaver A . Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon. Oncogene. 2008; 28(3):431-44. PMC: 2709457. DOI: 10.1038/onc.2008.389. View

19.

Daugherty K, Goode B . Functional surfaces on the p35/ARPC2 subunit of Arp2/3 complex required for cell growth, actin nucleation, and endocytosis. J Biol Chem. 2008; 283(24):16950-9. PMC: 2423265. DOI: 10.1074/jbc.M800783200. View

20.

Yamaguchi H . Pathological roles of invadopodia in cancer invasion and metastasis. Eur J Cell Biol. 2012; 91(11-12):902-7. DOI: 10.1016/j.ejcb.2012.04.005. View